SAB Biotherapeutics, Inc.

SABS·NasdaqCM
Compare
2.8300−0.1500 (−5.03%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours2.8800+0.0500 (+1.77%)Oct 12, 7:32 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2.9800
Open2.9700
Day range2.80002.9900
52-week range2.10005.1500
Off day high−5.35%
Off 52-week high−45.05%
Volume358.96K
Avg. volume (3M)503.34K
Market cap257.49M
EPS (TTM)-1.29
Forward P/E-2.97
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding90.99M
Short interest—
Earnings dateAug 6, 2026 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
SABS ABUS ZURA SANA CLYM AGMB
Market cap 257.49M 636.10M 383.32M 784.32M 622.03M 447.66M
P/E (TTM) — 5.3 — — — —
Forward P/E -3.0 -25.1 -5.8 -4.7 -10.8 -4.4
Price/book 1.1 3.2 1.9 5.1 2.6 3.6
Dividend yield — — — — — —
1-year change +29.00% −3.04% +3.63% −35.79% +450.00% −37.95%
Today −5.03% −1.66% 0.00% −6.09% −1.55% +0.11%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All SABS news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.